Toni Choueiri, Md

This study is testing a flexible treatment plan for advanced kidney cancer. It uses two immunotherapy drugs, nivolumab and ipilimumab. The plan changes based on how each patient's cancer initially responds to treatment, aiming to find the most effective strategy for long-term con…